ADVERTISEMENT

Alembic Pharma Q1 Results Review - Execution Remains A Key: Dolat Capital

Launch momentum is critical for U.S. growth; domestic business growth to remain steady.

<div class="paragraphs"><p>Close view of capsules. (Source: pexels/Suzy Hazelwood)</p></div>
Close view of capsules. (Source: pexels/Suzy Hazelwood)
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
You must be an existing Premium User
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit